Transmethylation and Oxidative Biomarkers in Children with Autism Spectrum Disorder: A Cross Sectional Study.
Autism spectrum disorder
Biomarkers
Oxidative stress
Transmethylation
Journal
Journal of autism and developmental disorders
ISSN: 1573-3432
Titre abrégé: J Autism Dev Disord
Pays: United States
ID NLM: 7904301
Informations de publication
Date de publication:
04 Sep 2024
04 Sep 2024
Historique:
accepted:
23
08
2024
medline:
4
9
2024
pubmed:
4
9
2024
entrez:
4
9
2024
Statut:
aheadofprint
Résumé
We aimed to investigate the potential role of biomarkers of transmethylation, oxidative stress, and mitochondrial dysfunction in children with Autism Spectrum Disorder (ASD) by comparing them with that of typically developing children (TDC) controls. We also tried to correlate them with severity of autism, sensory issues, behavioural comorbidities and developmental quotients 119 with ASD and 52 age and sex matched typically developing children (TDC) controls were enrolled excluding those with chronic-illness or on any antioxidant therapy/multivitamins/anti-epileptic drugs. Median levels of biomarkers - serum homocysteine, cysteine, methionine, urine uric acid-to-creatinine ratio, arterial lactate, serum vitamin E, vitamin B12, folate, Nε-carboxymethyllysine, Nω- carboxymethylarginine (CMA), dityrosine and MTHFR C677T polymorphism were calculated. Children with ASD were further characterised using Childhood Autism Rating Scale-2, Childhood behavioural checklist, child sensory profile 2 caregiver questionnaire, Developmental Profile 3 for any correlation with the various biomarker levels. The median level of serum homocysteine in ASD group was 9 μmol/L(Range, 7- 16μmol/L), which was significantly higher than controls 7 μmol/L(Range, 4- 11μmol/L)(p=0.01). The prevalence of hyper-homocystinemia(>15μmol/L) was 13.4% in ASD as compared to 3.8% in controls with a significant difference(p=0.04). Dityrosine level was higher among ASD children when compared to TDC (9.8 vs 2.2 counts per second(cps), p<0.001). No significant correlation was found between prevalence of hyperhomocysteinemia and severity of autism/DQ/behavioural issues. No significant difference was found between the median levels of other biomarkers. Results support possible role of transmethylation defects and oxidative stress in ASD pathogenesis. Further studies are warranted for a better understanding of ASD pathogenesis.
Identifiants
pubmed: 39230783
doi: 10.1007/s10803-024-06542-9
pii: 10.1007/s10803-024-06542-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Achenbach, T. M. (2011). Child Behavior Checklist. In J. S. Kreutzer, J. DeLuca, & B. Caplan (Eds.), Encyclopedia of Clinical Neuropsychology (pp. 546–552). Springer. https://doi.org/10.1007/978-0-387-79948-3_1529
Al-Beltagi, M. (2021). Autism medical comorbidities. World Journal of Clinical Pediatrics, 10(3), 15–28. https://doi.org/10.5409/wjcp.v10.i3.15
doi: 10.5409/wjcp.v10.i3.15
pubmed: 33972922
pmcid: 8085719
Al-Farsi, Y. M., Waly, M. I., Deth, R. C., Al-Sharbati, M. M., Al-Shafaee, M., Al-Farsi, O., Al-Khaduri, M. M., Gupta, I., Ali, A., Al-Khalili, M., Al-Adawi, S., Hodgson, N. W., & Ouhtit, A. (2013). Low folate and vitamin B12 nourishment is common in Omani children with newly diagnosed autism. Nutrition (Burbank, Los Angeles County, Calif.), 29(3), 537–541. https://doi.org/10.1016/j.nut.2012.09.014
doi: 10.1016/j.nut.2012.09.014
pubmed: 23287069
Al-Gadani, Y., El-Ansary, A., Attas, O., & Al-Ayadhi, L. (2009). Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children. Clinical Biochemistry, 42(10–11), 1032–1040. https://doi.org/10.1016/j.clinbiochem.2009.03.011
doi: 10.1016/j.clinbiochem.2009.03.011
pubmed: 19306862
Ali, A., Waly, M. I., Al-Farsi, Y. M., Essa, M. M., Al-Sharbati, M. M., & Deth, R. C. (2011). Hyperhomocysteinemia among Omani autistic children: A case-control study. Acta Biochimica Polonica, 58(4). https://doi.org/10.18388/abp.2011_2223
Alpern, G. D. (2007). Developmental Profile 3, DP-3: Manual. Western Psychological Services.
American Psychiatric Association (2013). Diagnostic and statistical Manual of Mental disorders (Fifth Edition). American Psychiatric Association. https://doi.org/10.1176/appi.books.9780890425596
doi: 10.1176/appi.books.9780890425596
and meta-analyses. Free Radical Biology and Medicine, 52(10), 2128–2141. https://doi.org/10.1016/j.freeradbiomed.2012.03.011
Anwar, A., Abruzzo, P. M., Pasha, S., Rajpoot, K., Bolotta, A., Ghezzo, A., Marini, M., Posar, A., Visconti, P., Thornalley, P. J., & Rabbani, N. (2018). Advanced glycation endproducts, dityrosine and arginine transporter dysfunction in autism—A source of biomarkers for clinical diagnosis. Molecular Autism, 9(1), 3. https://doi.org/10.1186/s13229-017-0183-3
doi: 10.1186/s13229-017-0183-3
pubmed: 29479405
pmcid: 5817812
Arora, N. K., Nair, M. K. C., Gulati, S., Deshmukh, V., Mohapatra, A., Mishra, D., Patel, V., Pandey, R. M., Das, B. C., Divan, G., Murthy, G. V. S., Sharma, T. D., Sapra, S., Aneja, S., Juneja, M., Reddy, S. K., Suman, P., Mukherjee, S. B., Dasgupta, R., & Vajaratkar, V. (2018). Neurodevelopmental disorders in children aged 2–9 years: Population-based burden estimates across five regions in India. PLOS Medicine, 15(7), e1002615. https://doi.org/10.1371/journal.pmed.1002615
doi: 10.1371/journal.pmed.1002615
pubmed: 30040859
pmcid: 6057634
Bae, Y. S., Choi, M. K., & Lee, W. J. (2010). Dual oxidase in mucosal immunity and host- microbe homeostasis. Trends in Immunology, 31(7), 278–287. https://doi.org/10.1016/j.it.2010.05.003
doi: 10.1016/j.it.2010.05.003
pubmed: 20579935
Chang, S., Linderholm, A., Franzi, L., Kenyon, N., Grasberger, H., & Harper, R. (2013). Dual oxidase regulates neutrophil recruitment in allergic airways. Free Radical Biology and Medicine, 65, 38–46. https://doi.org/10.1016/j.freeradbiomed.2013.06.012
doi: 10.1016/j.freeradbiomed.2013.06.012
pubmed: 23770197
Chen, L., Shi, X. J., Liu, H., Mao, X., Gui, L. N., Wang, H., & Cheng, Y. (2021). Oxidative stress marker aberrations in children with autism spectrum disorder: A systematic review and meta-analysis of 87 studies (N = 9109). Translational Psychiatry, 11(1), 15. https://doi.org/10.1038/s41398-020-01135-3
doi: 10.1038/s41398-020-01135-3
pubmed: 33414386
pmcid: 7791110
Chillemi, R., Angius, A., Persico, I., Sassu, A., Prodi, D. A., & Musumeci, S. (2006). Methylenetetrahydrofolate Reductase (MTHFR) from Mediterranean to Sub-saharan Areas. OnLine Journal of Biological Sciences, 6(1), 28–34. https://doi.org/10.3844/ojbsci.2006.28.34
doi: 10.3844/ojbsci.2006.28.34
Damodaran, L. P. M., & Arumugam, G. (2011). Urinary oxidative stress markers in children with autism. Redox Report, 16(5), 216–222. https://doi.org/10.1179/1351000211Y.0000000012
doi: 10.1179/1351000211Y.0000000012
pubmed: 22005342
Daniolou, S., Pandis, N., & Znoj, H. (2022). The efficacy of early interventions for children with Autism Spectrum disorders: A systematic review and Meta-analysis. Journal of Clinical Medicine, 11(17), 5100. https://doi.org/10.3390/jcm11175100
doi: 10.3390/jcm11175100
pubmed: 36079029
pmcid: 9457367
Dhillon, S., Hellings, A., J., & Butler, G., M (2011). Genetics and mitochondrial abnormalities in Autism Spectrum disorders:A review. Current Genomics, 12(5), 322–332. https://doi.org/10.2174/138920211796429745
doi: 10.2174/138920211796429745
pubmed: 22294875
pmcid: 3145262
Dunn, W. (2014). Sensory Profile 2: User’s Manual. Psych Corporation.
Frustaci, A., Neri, M., Cesario, A., Adams, J. B., & Domenici, E. Dalla Bernardina, B., &
Frye, R. E., Vassall, S., Kaur, G., Lewis, C., Karim, M., & Rossignol, D. (2019). Emerging biomarkers in autism spectrum disorder: A systematic review. Annals of Translational Medicine, 7(23), 792–792. https://doi.org/10.21037/atm.2019.11.53
doi: 10.21037/atm.2019.11.53
pubmed: 32042808
pmcid: 6989979
Gao, J., Cahill, C. M., Huang, X., Roffman, J. L., Lamon-Fava, S., Fava, M., Mischoulon, D., & Rogers, J. T. (2018). S-Adenosyl Methionine and Transmethylation pathways in Neuropsychiatric diseases throughout Life. Neurotherapeutics, 15(1), 156–175. https://doi.org/10.1007/s13311-017-0593-0
doi: 10.1007/s13311-017-0593-0
pubmed: 29340929
pmcid: 5794704
Goldani, A. A. S., Downs, S. R., Widjaja, F., Lawton, B., & Hendren, R. L. (2014). Biomarkers in Autism. Frontiers in Psychiatry, 5. https://doi.org/10.3389/fpsyt.2014.00100
Guo, T., Chen, H., Liu, B., Ji, W., & Yang, C. (2012). Methylenetetrahydrofolate Reductase Polymorphisms C677T and Risk of Autism in the Chinese Han Population. Genetic Testing and Molecular Biomarkers, 16(8), 968–973. https://doi.org/10.1089/gtmb.2012.0091
Guo, B. Q., Li, H. B., & Ding, S. B. (2020). Blood homocysteine levels in children with autism spectrum disorder: An updated systematic review and meta-analysis. Psychiatry Research, 291, 113283. https://doi.org/10.1016/j.psychres.2020.113283
doi: 10.1016/j.psychres.2020.113283
pubmed: 32763544
James, S. J., Cutler, P., Melnyk, S., Jernigan, S., Janak, L., Gaylor, D. W., & Neubrander, J. A. (2004). Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. The American Journal of Clinical Nutrition, 80(6), 1611–1617. https://doi.org/10.1093/ajcn/80.6.1611
doi: 10.1093/ajcn/80.6.1611
pubmed: 15585776
Jensen, A. R., Lane, A. L., Werner, B. A., McLees, S. E., Fletcher, T. S., & Frye, R. E. (2022). Modern biomarkers for Autism Spectrum Disorder: Future directions. Molecular Diagnosis & Therapy, 26(5), 483–495. https://doi.org/10.1007/s40291-022-00600-7
doi: 10.1007/s40291-022-00600-7
Kałużna-Czaplińska, J., Żurawicz, E., Michalska, M., & Rynkowski, J. (2013). A focus on homocysteine in autism. Acta Biochimica Polonica, 60(2). https://doi.org/10.18388/abp.2013_1963
Krajcovicova-Kudlackova, M., Valachovicova, M., Mislanova, C., Hudecova, Z., Sustrova, M., & Ostatnikova, D. (2009). Plasma concentrations of selected antioxidants in autistic children and adolescents. Bratislavske Lekarske Listy, 110(4), 247–250.
pubmed: 19507654
Kumar, A., Palfrey, H. A., Pathak, R., Kadowitz, P. J., Gettys, T. W., & Murthy, S. N. (2017). The metabolism and significance of homocysteine in nutrition and health. Nutrition & Metabolism, 14(1), 78. https://doi.org/10.1186/s12986-017-0233-z
doi: 10.1186/s12986-017-0233-z
Li, B., Xu, Y., Pang, D., Zhao, Q., Zhang, L., Li, M., Li, W., Duan, G., & Zhu, C. (2022). Interrelation between homocysteine metabolism and the development of autism spectrum disorder in children. Frontiers in Molecular Neuroscience, 15, 947513. https://doi.org/10.3389/fnmol.2022.947513
doi: 10.3389/fnmol.2022.947513
pubmed: 36046711
pmcid: 9421079
Li, Y. A., Chen, Z. J., Li, X. D., Gu, M. H., Xia, N., Gong, C., Zhou, Z. W., Yasin, G., Xie, H. Y., Wei, X. P., Liu, Y. L., Han, X. H., Lu, M., Xu, J., & Huang, X. L. (2022b). Epidemiology of autism spectrum disorders: Global burden of disease 2019 and bibliometric analysis of risk factors. Frontiers in Pediatrics, 10, 972809. https://doi.org/10.3389/fped.2022.972809
doi: 10.3389/fped.2022.972809
pubmed: 36545666
pmcid: 9760802
Liu, X., Lin, J., Zhang, H., Khan, N. U., Zhang, J., Tang, X., Cao, X., & Shen, L. (2022). Oxidative stress in Autism Spectrum disorder—current progress of mechanisms and biomarkers. Frontiers in Psychiatry, 13, 813304. https://doi.org/10.3389/fpsyt.2022.813304
doi: 10.3389/fpsyt.2022.813304
pubmed: 35299821
pmcid: 8921264
Lobo, V., Patil, A., Phatak, A., & Chandra, N. (2010). Free radicals, antioxidants and functional foods: Impact on human health. Pharmacognosy Reviews, 4(8), 118. https://doi.org/10.4103/0973-7847.70902
doi: 10.4103/0973-7847.70902
pubmed: 22228951
pmcid: 3249911
Maenner, M. J., Warren, Z., Williams, A. R., Amoakohene, E., Bakian, A. V., Bilder, D. A., Durkin, M. S., Fitzgerald, R. T., Furnier, S. M., Hughes, M. M., Ladd-Acosta, C. M., McArthur, D., Pas, E. T., Salinas, A., Vehorn, A., Williams, S., Esler, A., Grzybowski, A., Hall-Lande, J., & Shaw, K. A. (2023). Prevalence and characteristics of Autism Spectrum Disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2020. MMWR Surveillance Summaries, 72(2), 1–14. https://doi.org/10.15585/mmwr.ss7202a1
doi: 10.15585/mmwr.ss7202a1
pmcid: 10042614
McQuaid, G. A., Pelphrey, K. A., Bookheimer, S. Y., Dapretto, M., Webb, S. J., Bernier, R. A., McPartland, J. C., Van Horn, J. D., & Wallace, G. L. (2021). The gap between IQ and adaptive functioning in autism spectrum disorder: Disentangling diagnostic and sex differences. Autism: The International Journal of Research and Practice, 25(6), 1565–1579. https://doi.org/10.1177/1362361321995620
doi: 10.1177/1362361321995620
pubmed: 33715473
Murphy, M. P., Holmgren, A., Larsson, N. G., Halliwell, B., Chang, C. J., Kalyanaraman, B., Rhee, S. G., Thornalley, P. J., Partridge, L., Gems, D., Nyström, T., Belousov, V., Schumacker, P. T., & Winterbourn, C. C. (2011). Unraveling the biological roles of reactive oxygen species. Cell Metabolism, 13(4), 361–366. https://doi.org/10.1016/j.cmet.2011.03.010
doi: 10.1016/j.cmet.2011.03.010
pubmed: 21459321
pmcid: 4445605
Mutchinick, O. M., López, M. A., Luna, L., Waxman, J., & Babinsky, V. E. (1999). High prevalence of the Thermolabile Methylenetetrahydrofolate reductase variant in Mexico: A Country with a very high prevalence of neural tube defects. Molecular Genetics and Metabolism, 68(4), 461–467. https://doi.org/10.1006/mgme.1999.2939
doi: 10.1006/mgme.1999.2939
pubmed: 10607475
Oh, M., Kim, S. A., & Yoo, H. J. (2020). Higher lactate level and lactate-to-pyruvate ratio in Autism Spectrum Disorder. Experimental Neurobiology, 29(4), 314–322. https://doi.org/10.5607/en20030
doi: 10.5607/en20030
pubmed: 32921643
pmcid: 7492845
Osredkar, J., Gosar, D., Maček, J., Kumer, K., Fabjan, T., Finderle, P., Šterpin, S., Zupan, M., & Jekovec Vrhovšek, M. (2019). Urinary markers of oxidative stress in children with Autism Spectrum disorder (ASD). Antioxidants (Basel Switzerland), 8(6), 187. https://doi.org/10.3390/antiox8060187
doi: 10.3390/antiox8060187
pubmed: 31226814
Paşca, S. P., Dronca, E., Kaucsár, T., Crǎciun, E. C., Endreffy, E., Ferencz, B. K., Iftene, F., Benga, I., Cornean, R., Banerjee, R., & Dronca, M. (2009). One carbon metabolism disturbances and the C677T MTHFR gene polymorphism in children with autism spectrum disorders. Journal of Cellular and Molecular Medicine, 13(10), 4229–4238. https://doi.org/10.1111/j.1582-4934.2008.00463.x44
doi: 10.1111/j.1582-4934.2008.00463.x44
pubmed: 19267885
Ristori, M. V., Mortera, S. L., Marzano, V., Guerrera, S., Vernocchi, P., Ianiro, G., Gardini, S., Torre, G., Valeri, G., Vicari, S., Gasbarrini, A., & Putignani, L. (2020). Proteomics and metabolomics approaches towards a functional insight onto AUTISM Spectrum disorders: Phenotype stratification and Biomarker Discovery. International Journal of Molecular Sciences, 21(17), 6274. https://doi.org/10.3390/ijms21176274
doi: 10.3390/ijms21176274
pubmed: 32872562
pmcid: 7504551
Sadewa, A. H., Sunarti, Sutomo, R., Hayashi, C., Lee, M. J., Ayaki, H., Sofro, A. S. M., Matsuo, M., & Nishio, H. (2002). The C677T mutation in the methylenetetrahydrofolate reductase gene among the Indonesian javanese population. The Kobe Journal of Medical Sciences, 48(5–6), 137–144.
pubmed: 12594357
Salari, N., Rasoulpoor, S., Rasoulpoor, S., Shohaimi, S., Jafarpour, S., Abdoli, N., Khaledi- Paveh, B., & Mohammadi, M. (2022). The global prevalence of autism spectrum disorder: A comprehensive systematic review and meta-analysis. Italian Journal of Pediatrics, 48(1), 112. https://doi.org/10.1186/s13052-022-01310-w
doi: 10.1186/s13052-022-01310-w
pubmed: 35804408
pmcid: 9270782
Santos, P. A. C., dos, Longo, D., Brandalize, A. P. C., & Schüler-Faccini, L. (2010). MTHFR C677T is not a risk factor for autism spectrum disorders in South Brazil. Psychiatric Genetics, 20(4), 187–189. https://doi.org/10.1097/YPG.0b013e32833a2220
doi: 10.1097/YPG.0b013e32833a2220
pubmed: 20440228
Saraswathy, K. N., Asghar, M., Samtani, R., Murry, B., Mondal, P. R., Ghosh, P. K., & Sachdeva, M. P. (2012). Spectrum of MTHFR gene SNPs C677T and A1298C: A study among 23 population groups of India. Molecular Biology Reports, 39(4), 5025–5031. https://doi.org/10.1007/s11033-011-1299-8
doi: 10.1007/s11033-011-1299-8
pubmed: 22147263
Sauer, A. K., Stanton, J. E., Hans, S., & Grabrucker, A. M. (2021). Autism Spectrum disorders: Etiology and Pathology. In A. M. Grabrucker (Ed.), Autism Spectrum disorders. Exon. http://www.ncbi.nlm.nih.gov/books/NBK573613/
Sener, E. F., Oztop, D. B., & Ozkul, Y. (2014). MTHFR Gene C677T Polymorphism in Autism Spectrum Disorders. Genetics Research International, 2014, 698574. https://doi.org/10.1155/2014/698574
Sies, H., Berndt, C., & Jones, D. P. (2017). Oxidative stress. Annual Review of Biochemistry, 86(1), 715–748. https://doi.org/10.1146/annurev-biochem-061516-045037
doi: 10.1146/annurev-biochem-061516-045037
pubmed: 28441057
Stanger, O., Fowler, B., Piertzik, K., Huemer, M., Haschke-Becher, E., Semmler, A., Lorenzl, S., & Linnebank, M. (2009). Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: Review and treatment recommendations. Expert Review of Neurotherapeutics, 9(9), 1393–1412. https://doi.org/10.1586/ern.09.75
doi: 10.1586/ern.09.75
pubmed: 19769453
Vargason, T., Kruger, U., McGuinness, D. L., Adams, J. B., Geis, E., Gehn, E., Coleman, D., & Hahn, J. (2018). Investigating plasma amino acids for differentiating individuals with autism spectrum disorder and typically developing peers. Research in Autism Spectrum Disorders, 50, 60–72. https://doi.org/10.1016/j.rasd.2018.03.004
doi: 10.1016/j.rasd.2018.03.004
pubmed: 29682004
pmcid: 5903290
Vaughan, C. A. Test Review: E., Schopler, M. E., Van Bourgondien, G. J., & Wellman (2011). & S. R. Love Childhood Autism Rating Scale (2nd ed.). Los Angeles, CA: Western Psychological Services, 2010. Journal of Psychoeducational Assessment, 29(5), 489– 493. https://doi.org/10.1177/0734282911400873
Yadav, U., Kumar, P., Gupta, S., & Rai, V. (2017). Distribution of MTHFR C677T Gene Polymorphism in Healthy North Indian Population and an updated Meta-analysis. Indian Journal of Clinical Biochemistry, 32(4), 399–410. https://doi.org/10.1007/s12291-016-0619-0
doi: 10.1007/s12291-016-0619-0
pubmed: 29062171